Key Takeaways The U.S. Food and Drug Administrtion is ending sale of compounded versions of Ozempic, Wegovy and similar ...

Employers have the opportunity to lead by example: to stop treating obesity as invisible and start addressing it as the ...

The debate surrounding Ozempic and similar weight loss drugs highlights the benefits and drawbacks of medical weight loss, ...

It may not be the mythical fountain of youth, but the strength of the body's immune system, or immune resilience, could hold ...

Researchers have discovered that tirzepatide and semaglutide impact energy metabolism in distinct ways. New animal research ...

Novo Nordisk's limited-time coupon on Wegovy was simultaneously promoted by telehealth companies Ro and Wegovy ...

After four years, those who took GLP-1 drugs had a 7% lower risk of developing an obesity-related cancer and an 8% lower risk ...

While some Ozempic faces are appearing older with sunken cheeks, gaunt eyes and sagging neck skin — that doesn’t seem to be ...

Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of the medication.

A 26-page report ordered by President Trump makes several claims about the causes of chronic illnesses among children.

India's healthtech space is expected to witness disruption as weight loss drugs Ozempic and Mounjaro enter the market through ...

The "Make America Healthy Again" report, commissioned by President Trump, highlights ultraprocessed foods and environmental ...